ArticleRenal failure2025
Increased inflammation burden index increasing the risk of poor prognosis in patients with chronic kidney disease in NHANES study.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Difficult-to-Treat Rheumatoid Arthritis in Saudi Arabia: Clinical Characteristics and Associated Factors in a Multicentre Study.Open access rheumatology : research and reviews · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSeveral studies illustrated high level of inflammation is an important factor affecting the poor prognosis of patients with chronic kidney disease. Inflammatory burden index (IBI) is a composite maker by incorporating a variety of inflammatory markers to facilitate more in-depth assessment for systemic inflammation. The purpose of this research is to examine the correlation between IBI and prognosis in CKD population of American adults.
methodsThis study included CKD patients recruited from the U.S. National Health and Nutrition Examination Survey (NHANES) database from 1999 to 2010. The primary endpoints were identified as all-cause and cardiovascular mortality, with a median follow-up period of 83 (IQR 83-172) months. Associations between IBI and endpoints were explored using multivariable in-depth regressions, restricted cubic splines (RCS) and subgroup analyses.
resultsThe research enrolled 3,975 subjects. During the follow-up period, there were 2,016 all-cause deaths and 628 cardiovascular deaths. Participants were divided into four groups based on IBI quartiles. Fully adjusted multivariate Cox regression analysis revealed increased IBI was associated with increased both all-cause and cardiovascular mortality risk [Quartile 4 vs. Quartile 1: all-cause mortality, HR = 1.37 (1.21-1.55); cardiovascular mortality, HR = 1.47 (1.17-1.84)]. The RCS analysis further supported a positive relationship between IBI and both endpoints.
conclusionsThe IBI is strong correlated to the mortality of CKD individuals. Elevated levels of inflammation increased the risk of adverse clinical endpoints.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.